Volume6, Issue0 (2020)

Volume

Table of Contents (170 articles)

Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a western perspective

Ann Farrell, ... Jessica Howell

Ion channels in liver diseases and hepatocellular carcinoma: potential tools for diagnosis, prognosis, and therapy

María de Guadalupe Chávez-López, ... Javier Camacho

Coffee protection against the development of hepatocellular carcinoma: review article

Kellyane S. D. Carvalho, ... Helma P. Cotrim

First cases of MPV17 related mitochondrial DNA depletion syndrome with compound heterozygous mutations in p.R50Q/p.R50W: a case report

Shuichiro Umetsu, ... Tomoo Fujisawa

Interim results from ongoing Phase III placebo-controlled, randomized trial of hepcortespenlisimut-L for advanced hepatocellular carcinoma indication

Aldar S. Bourinbaiar, ... Vichai Jirathitikal

The mechanism of dysbiosis in alcoholic liver disease leading to liver cancer

Nahum Méndez-Sánchez, ... David Q.-H. Wang

Microwave ablation of hepatocellular carcinomas in octogenarians

Jacob Freedman

Cytotoxic immune cell-based immunotherapy for hepatocellular carcinoma

Jing Li, ... Xuefu Wang

Association between hereditary hemochromatosis and hepatocellular carcinoma: a comprehensive review

Aparna Jayachandran, ... Darrell H. G. Crawford

Hepatocellular carcinoma and hepatitis C virus infection in Latin America: epidemiology, diagnosis and treatment

Marina Galicia-Moreno, ... Juan Armendariz-Borunda

Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment

Michela Emma Burlone, ... Mario Pirisi

Animal models for hepatocellular carcinoma arising from alcoholic and metabolic liver diseases

Ken Liu, ... Geoffrey W. McCaughan

Treatment efficacy for patients with chronic hepatitis C and preexisting hepatocellular carcinoma by directly acting antivirals

Chia-Yen Dai, ... Ming-Lung Yu

Frailty and Liver resection: where do we stand?

Georgios S. Sioutas, ... Georgios Tsoulfas

The impact of direct-acting antivirals on hepatitis C associated hepatocellular carcinoma

Tai-Ping Lee, ... David Bernstein

Impact of direct-acting antivirals on de novo occurrence of hepatocellular carcinoma in hepatitis C virus patients

Ming Yang, ... Lai Wei

Treatment options for recurrence of hepatocellular carcinoma after surgical resection: review of the literature and current recommendations for management

Francesco Pasini, ... Giorgio Ercolani

Distinctive magnetic resonance imaging findings of hepatocellular carcinoma after hepatitis C virus eradication with direct-acting antivirals

Takao Shimizu, ... Namiki Izumi

The interplay between direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C

Sun Hong Yoo, ... Jung Hyun Kwon

Direct-acting antivirals and risk of hepatocellular carcinoma: from genetic signature to metabolic risk factors

Stefano Gitto, ... Erica Villa

Recurrence of hepatocellular carcinoma following deceased donor liver transplantation: case series

Cem Simsek, ... Behnam Saberi

Direct acting antivirals therapy and hepatocellular carcinoma risk in patients with hepatitis C virus

Monika Pazgan-Simon

Prehabilitation in elderly patients scheduled for liver resection and protocol for Recovery Of Surgery in Elderly

Ramkumar Mohan, ... Vishal G. Shelat

Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly

Giovanni Marasco, ... Davide Festi

Predictive factors for hepatocellular carcinoma recurrence after curative treatments

Giovanni Marasco, ... Antonio Colecchia

Personalized T-cell therapy in liver transplanted patients with hepatitis B virus related hepatocellular carcinoma

Morteza Hafezi, ... Anthony Tan

Recent advances regarding tumor microenvironment and immunotherapy in hepatocellular carcinoma

Wei Qin, ... Xun-Di Xu

Mechanisms and immunotherapies of HBV- and NAFLD-related hepatocellular carcinoma

Xiao-Jia Song, ... Chun-Hong Ma

Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis

Ze-long Yang, ... Yong Chen

Epidemiology of hepatocellular carcinoma in metabolic liver disease

Stefano Bellentani

Conventional type 1 dendritic cells in protective antitumor immunity and its potential in hepatocellular carcinoma

Chunfeng Qu, ... Shao-Yan Cheng

Stereotactic body radiation therapy for the management of HCC

Jia-Xin Li, ... Yong Zeng

The advancement of immunotherapy in hepatocellular carcinoma

Ling Ni, ... Chen Dong

Role of laparoscopic and robotic liver resection compared to open surgery in elderly hepatocellular carcinoma patients: a systematic review and meta-analysis

Alberto Brolese, ... Francesco A. Ciarleglio

Emerging risk factors for nonalcoholic fatty liver disease associated hepatocellular carcinoma

Jihane N. Benhammou, ... Mohamed El-Kabany

Imaging biomarkers for predicting poor prognosis of hepatocellular carcinoma: a review

Yun Zhang, ... Bin Song

The advances in immunotherapy for hepatocellular carcinoma

Fan Zhang, ... Yumin Li

Diagnosing non-hepatocellular carcinoma malignancies on CT/MRI and contrast enhanced ultrasound: the Liver Imaging Reporting and Data System approach

Kathryn J. Fowler, ... Tae Kyoung Kim

β-catenin in intranuclear inclusions of hepatocellular carcinoma

Suzan Schwertheim, ... Hideo Andreas Baba

Intraarterial and intravenous contrast enhanced CT and MR imaging of multi-step hepatocarcinogenesis defining the early stage of hepatocellular carcinoma development

Satoshi Kobayashi, ... Tetsuya Minami

Genetics of alcohol-related hepatocellular carcinoma - its role in risk prediction

Ken Liu, ... Devanshi Seth

Comprehending the therapeutic effects of stereotactic body radiation therapy for small hepatocellular carcinomas based on imagings

Zhao-Chong Zeng, ... Qian-Qian Zhao

Imaging assessment after SBRT for hepatocellular carcinoma

Connie Yip, ... Vicky Goh

Contrast-enhanced ultrasonography with Sonazoid in hepatocellular carcinoma diagnosis

Yasunori Minami, ... Masatoshi Kudo

Pathomolecular characterization of HCC in non-cirrhotic livers

Archana Rastogi

Contrast-enhanced ultrasound liver reporting and data system for hepatocellular carcinoma diagnosis

Alexander M. Vezeridis, ... Yuko Kono

Can radiotherapy finally “go live” in the management of liver metastases?

Reggie G. John, ... Balamurugan A. Vellayappan

Long-term survival of occult hepatitis B associated hepatocellular carcinoma following surgery and antiviral therapy

Tina Boortalary, ... Hie-Won Hann

Combined transarterial chemoembolization and stereotactic body radiation therapy as a bridge therapy to liver transplant for hepatocellular carcinoma

Bui Quang Bieu, ... Mai Hong Bang

Risk factors for hepatocellular carcinoma recurrence after liver transplantation

Pierluigi Toniutto, ... Davide Bitetto

Role of imaging in management of hepatocellular carcinoma: surveillance, diagnosis, and treatment response

Azeez Osho, ... Amit G. Singal

Hypoalbuminemia: an underestimated, vital characteristic of hospitalized COVID-19 positive patients?

Giuliano Ramadori

Liver imaging reporting and data system and CT/MRI diagnosis of hepatocellular carcinoma

Devaraju Kanmaniraja, ... Victoria Chernyak

Global pattern and trend of liver cancer survival: a systematic review of population-based studies

Yu-Fei Jiang, ... Yong-Bing Xiang

Contrast-enhanced ultrasound of focal liver masses

Stephanie R. Wilson, ... Christina Merrill

Viral hepatitis as a risk factor for the development of hepatocellular carcinoma

Saleh A. Alqahtani, ... Massimo Colombo

Alternative approach of hepatocellular carcinoma surveillance: abbreviated MRI

Ryan L. Brunsing, ... Robert M. Marks

Stereotactic body radiation therapy for primary liver tumors with adverse factors

Takuya Shimizuguchi, ... Katsuyuki Karasawa

Comparison and analysis of the efficacy of drug therapy for liver cancer

Philippe Merle, ... Miroslava Subic

The role of genetic factors in HBV-related HCC: perspectives from local genetic backgrounds and clinical epidemiology

Dar-In Tai, ... Jennifer Tai

Detection of circulating tumor cells in hepatocellular carcinoma: applications in diagnosis, prognosis prediction and personalized treatment

Peng-Xiang Wang, ... Xin-Rong Yang

Evaluation and impact of different biomarkers for early detection of hepatocellular carcinoma

Jan Best, ... Ali Canbay

Prognostic ability of inflammation-based markers in radioembolization for hepatocellular carcinoma

Grant Yoneoka, ... Linda L. Wong

Immunotherapy of hepatocellular carcinoma with infection of hepatitis B or C virus

Cecilia Monge Bonilla, ... Changqing Xie

Validation of novel Japanese indication criteria and biomarkers among living donor liver transplantation recipients with hepatocellular carcinoma - a single center retrospective study

Akihiko Ichida, ... Kiyoshi Hasegawa

CT and MRI of the liver for hepatocellular carcinoma

Cynthia Santillan

Cutaneous toxicities of targeted therapies in the treatment of hepatocellular carcinoma

Tarik Silk, ... Jennifer Wu

For dietary advice in end-stage liver cirrhosis resting metabolic rate should be measured, not estimated

Daphne Bot, ... Bart van Hoek

Beneficial effects of coffee in non-alcoholic fatty liver disease: a narrative review

Alessio Calabrò, ... Ludovico Abenavoli

Systemic therapy for advanced cholangiocarcinoma: new options on the horizon

Saleh A. Alqahtani, ... Massimo Colombo

Post liver transplant recurrence in patients with hepatocellular carcinoma: not necessarily the end of the road!

Prashant Bhangui, ... AS Soin

Should selection criteria for HCC be the same (or different) between LDLT and DDLT?

Flavia Feier

Living donor liver transplantation for patients with advanced hepatocellular carcinoma

J. Michael Cullen, ... Nicolas Goldaracena

From nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease: is it time for a change of terminology?

Giovanni Targher, ... Christopher D. Byrne

The transcontinental variability of nonalcoholic fatty liver disease

Claudia P. Oliveira, ... Arun J. Sanyal

Advances in minimally invasive surgery for hepatocellular carcinoma

Cun-Zhen Zhang, ... Nan Li

Prevalence and incidence of intra- and extrahepatic complications of NAFLD in patients with type 2 diabetes mellitus

Alessandro Mantovani, ... Andrea Dalbeni

Current status of laparoscopic repeat liver resection for hepatocellular carcinoma

Zenichi Morise

p53 functional loss, stemness and hepatocellular carcinoma

Claude Caron de Fromentel, ... Massimo Levrero

Current status of laparoscopic repeat liver resection for recurrent hepatocellular carcinoma

Daisuke Hokuto, ... Masayuki Sho

Robotic-assisted laparoscopic liver resection in hepatocellular carcinoma

Kevin P. Labadie, ... Jonathan G. Sham

Diabetes and NAFLD: a high-risk cohort with definite therapeutic potential

Lucia Brodosi, ... Maria Letizia Petroni

Sex disparity in hepatocellular carcinoma owing to NAFLD and non-NAFLD etiology: epidemiological findings and pathobiological mechanisms

Amedeo Lonardo, ... Ayako Suzuki

Nonalcoholic fatty liver disease in lean subjects: is it all metabolic-associated fatty liver disease?

Mariana Verdelho Machado

Genetic risk factors associated with NAFLD

Dong Yun Kim, ... Jun Yong Park

Genetic risk factors associated with NAFLD

Dong Yun Kim, Jun Yong Park

Nonalcoholic fatty liver disease in lean subjects: is it all metabolic-associated fatty liver disease?

Mariana Verdelho Machado

Sex disparity in hepatocellular carcinoma owing to NAFLD and non-NAFLD etiology: epidemiological findings and pathobiological mechanisms

Amedeo Lonardo, ... Ayako Suzuki

Diabetes and NAFLD: a high-risk cohort with definite therapeutic potential

Lucia Brodosi, ... Maria Letizia Petroni

Current status of laparoscopic repeat liver resection for recurrent hepatocellular carcinoma

Daisuke Hokuto, ... Masayuki Sho

p53 functional loss, stemness and hepatocellular carcinoma

Claude Caron de Fromentel

, Massimo Levrero

Current status of laparoscopic repeat liver resection for hepatocellular carcinoma

Zenichi Morise

Prevalence and incidence of intra- and extrahepatic complications of NAFLD in patients with type 2 diabetes mellitus

Alessandro Mantovani, ... Andrea Dalbeni

Advances in minimally invasive surgery for hepatocellular carcinoma

Cun-Zhen Zhang, Nan Li

Living donor liver transplantation for patients with advanced hepatocellular carcinoma

J. Michael Cullen, ... Nicolas Goldaracena

Should selection criteria for HCC be the same (or different) between LDLT and DDLT?

Flavia Feier

The role of genetic factors in HBV-related HCC: perspectives from local genetic backgrounds and clinical epidemiology

Dar-In Tai, Jennifer Tai

Cutaneous toxicities of targeted therapies in the treatment of hepatocellular carcinoma

Tarik Silk, Jennifer Wu

The transcontinental variability of nonalcoholic fatty liver disease

Claudia P. Oliveira

, ... Arun J. Sanyal

Post liver transplant recurrence in patients with hepatocellular carcinoma: not necessarily the end of the road!

Prashant Bhangui

, ... AS Soin

Systemic therapy for advanced cholangiocarcinoma: new options on the horizon

Saleh A. Alqahtani, Massimo Colombo

Beneficial effects of coffee in non-alcoholic fatty liver disease: a narrative review

Alessio Calabrò, ... Ludovico Abenavoli

Immunotherapy of hepatocellular carcinoma with infection of hepatitis B or C virus

Cecilia Monge Bonilla, ... Changqing Xie

Prognostic ability of inflammation-based markers in radioembolization for hepatocellular carcinoma

Grant Yoneoka, ... Linda L. Wong

Stereotactic body radiation therapy for primary liver tumors with adverse factors

Takuya Shimizuguchi, ... Katsuyuki Karasawa

Robotic-assisted laparoscopic liver resection in hepatocellular carcinoma

Kevin P. Labadie, ... Jonathan G. Sham

From nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease: is it time for a change of terminology?

Giovanni Targher, Christopher D. Byrne

CT and MRI of the liver for hepatocellular carcinoma

Cynthia Santillan

Evaluation and impact of different biomarkers for early detection of hepatocellular carcinoma

Jan Best, ... Ali Canbay

Detection of circulating tumor cells in hepatocellular carcinoma: applications in diagnosis, prognosis prediction and personalized treatment

Peng-Xiang Wang, ... Xin-Rong Yang

Comparison and analysis of the efficacy of drug therapy for liver cancer

Philippe Merle, Miroslava Subic

Alternative approach of hepatocellular carcinoma surveillance: abbreviated MRI

Ryan L. Brunsing, ... Robert M. Marks

Viral hepatitis as a risk factor for the development of hepatocellular carcinoma

Saleh A. Alqahtani, Massimo Colombo

Contrast-enhanced ultrasound of focal liver masses

Stephanie R. Wilson, Christina Merrill

Can radiotherapy finally “go live” in the management of liver metastases?

Reggie G. John, ... Balamurugan A. Vellayappan

Role of imaging in management of hepatocellular carcinoma: surveillance, diagnosis, and treatment response

Azeez Osho, ... Amit G. Singal

Validation of novel Japanese indication criteria and biomarkers among living donor liver transplantation recipients with hepatocellular carcinoma - a single center retrospective study

Akihiko Ichida, ... Kiyoshi Hasegawa

Contrast-enhanced ultrasound liver reporting and data system for hepatocellular carcinoma diagnosis

Alexander M. Vezeridis, Yuko Kono

Global pattern and trend of liver cancer survival: a systematic review of population-based studies

Yu-Fei Jiang, ... Yong-Bing Xiang

Liver imaging reporting and data system and CT/MRI diagnosis of hepatocellular carcinoma

Devaraju Kanmaniraja, Victoria Chernyak

Risk factors for hepatocellular carcinoma recurrence after liver transplantation

Pierluigi Toniutto

, ... Davide Bitetto

Combined transarterial chemoembolization and stereotactic body radiation therapy as a bridge therapy to liver transplant for hepatocellular carcinoma

Bui Quang Bieu, ... Mai Hong Bang

Long-term survival of occult hepatitis B associated hepatocellular carcinoma following surgery and antiviral therapy

Tina Boortalary, ... Hie-Won Hann

Pathomolecular characterization of HCC in non-cirrhotic livers

Archana Rastogi

Contrast-enhanced ultrasonography with Sonazoid in hepatocellular carcinoma diagnosis

Yasunori Minami, Masatoshi Kudo

For dietary advice in end-stage liver cirrhosis resting metabolic rate should be measured, not estimated

Daphne Bot, ... Bart van Hoek

Imaging assessment after SBRT for hepatocellular carcinoma

Connie Yip

, ... Vicky Goh

Comprehending the therapeutic effects of stereotactic body radiation therapy for small hepatocellular carcinomas based on imagings

Zhao-Chong Zeng, ... Qian-Qian Zhao

Genetics of alcohol-related hepatocellular carcinoma - its role in risk prediction

Ken Liu, ... Devanshi Seth

β-catenin in intranuclear inclusions of hepatocellular carcinoma

Suzan Schwertheim, ... Hideo Andreas Baba

The advances in immunotherapy for hepatocellular carcinoma

Fan Zhang, Yumin Li

Stereotactic body radiation therapy for the management of HCC

Jia-Xin Li, ... Yong Zeng

Conventional type 1 dendritic cells in protective antitumor immunity and its potential in hepatocellular carcinoma

Chunfeng Qu, ... Shao-Yan Cheng

Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis

Ze-long Yang, ... Yong Chen

Intraarterial and intravenous contrast enhanced CT and MR imaging of multi-step hepatocarcinogenesis defining the early stage of hepatocellular carcinoma development

Satoshi Kobayashi, ... Tetsuya Minami

Emerging risk factors for nonalcoholic fatty liver disease associated hepatocellular carcinoma

Jihane N. Benhammou, ... Mohamed El-Kabany

Role of laparoscopic and robotic liver resection compared to open surgery in elderly hepatocellular carcinoma patients: a systematic review and meta-analysis

Alberto Brolese, ... Francesco A. Ciarleglio

Predictive factors for hepatocellular carcinoma recurrence after curative treatments

Giovanni Marasco

, ... Antonio Colecchia

Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly

Giovanni Marasco, ... Davide Festi

Impact of direct-acting antivirals on de novo occurrence of hepatocellular carcinoma in hepatitis C virus patients

Ming Yang, ... Lai Wei

Imaging biomarkers for predicting poor prognosis of hepatocellular carcinoma: a review

Yun Zhang, ... Bin Song

Epidemiology of hepatocellular carcinoma in metabolic liver disease

Stefano Bellentani

Hypoalbuminemia: an underestimated, vital characteristic of hospitalized COVID-19 positive patients?

Giuliano Ramadori

Mechanisms and immunotherapies of HBV- and NAFLD-related hepatocellular carcinoma

Xiao-Jia Song, Chun-Hong Ma

Treatment options for recurrence of hepatocellular carcinoma after surgical resection: review of the literature and current recommendations for management

Francesco Pasini, ... Giorgio Ercolani

The advancement of immunotherapy in hepatocellular carcinoma

Ling Ni, ... Chen Dong

Recent advances regarding tumor microenvironment and immunotherapy in hepatocellular carcinoma

Wei Qin, ... Xun-Di Xu

Personalized T-cell therapy in liver transplanted patients with hepatitis B virus related hepatocellular carcinoma

Morteza Hafezi, ... Anthony Tan

Direct-acting antivirals and risk of hepatocellular carcinoma: from genetic signature to metabolic risk factors

Stefano Gitto

, Erica Villa

The impact of direct-acting antivirals on hepatitis C associated hepatocellular carcinoma

Tai-Ping Lee, David Bernstein

Hepatocellular carcinoma and hepatitis C virus infection in Latin America: epidemiology, diagnosis and treatment

Marina Galicia-Moreno, ... Juan Armendariz-Borunda

Diagnosing non-hepatocellular carcinoma malignancies on CT/MRI and contrast enhanced ultrasound: the Liver Imaging Reporting and Data System approach

Kathryn J. Fowler, ... Tae Kyoung Kim

Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a western perspective

Ann Farrell, ... Jessica Howell

Direct acting antivirals therapy and hepatocellular carcinoma risk in patients with hepatitis C virus

Monika Pazgan-Simon

Treatment efficacy for patients with chronic hepatitis C and preexisting hepatocellular carcinoma by directly acting antivirals

Chia-Yen Dai, ... Ming-Lung Yu

Cytotoxic immune cell-based immunotherapy for hepatocellular carcinoma

Jing Li, ... Xuefu Wang

Ion channels in liver diseases and hepatocellular carcinoma: potential tools for diagnosis, prognosis, and therapy

María de Guadalupe Chávez-López, ... Javier Camacho

Prehabilitation in elderly patients scheduled for liver resection and protocol for Recovery Of Surgery in Elderly

Ramkumar Mohan, ... Vishal G. Shelat

Distinctive magnetic resonance imaging findings of hepatocellular carcinoma after hepatitis C virus eradication with direct-acting antivirals

Takao Shimizu, ... Namiki Izumi

Recurrence of hepatocellular carcinoma following deceased donor liver transplantation: case series

Cem Simsek, ... Behnam Saberi

Microwave ablation of hepatocellular carcinomas in octogenarians

Jacob Freedman

The interplay between direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C

Sun Hong Yoo, Jung Hyun Kwon

Association between hereditary hemochromatosis and hepatocellular carcinoma: a comprehensive review

Aparna Jayachandran, ... Darrell H. G. Crawford

Animal models for hepatocellular carcinoma arising from alcoholic and metabolic liver diseases

Ken Liu, ... Geoffrey W. McCaughan

Coffee protection against the development of hepatocellular carcinoma: review article

Kellyane S. D. Carvalho, Helma P. Cotrim

The mechanism of dysbiosis in alcoholic liver disease leading to liver cancer

Nahum Méndez-Sánchez

, ... David Q.-H. Wang

Frailty and Liver resection: where do we stand?

Georgios S. Sioutas, ... Georgios Tsoulfas

Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment

Michela Emma Burlone, ... Mario Pirisi

Interim results from ongoing Phase III placebo-controlled, randomized trial of hepcortespenlisimut-L for advanced hepatocellular carcinoma indication

Aldar S. Bourinbaiar, ... Vichai Jirathitikal

First cases of MPV17 related mitochondrial DNA depletion syndrome with compound heterozygous mutations in p.R50Q/p.R50W: a case report

Shuichiro Umetsu, ... Tomoo Fujisawa